Bank of New York Mellon’s Enfusion, Inc. ENFN Stock Holding History

Bank of New York Mellon's ENFN Position: Q2 2025 in Review

Bank of New York Mellon sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 124,641 shares — an estimated $1.39M sold.

Bank of New York Mellon first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $9.7M in Q1 2022. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

• Bank of New York Mellon reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
• Bank of New York Mellon sold 124,641 Enfusion, Inc. shares in Q2 2025, an estimated $1.39M.
• Bank of New York Mellon first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
• Bank of New York Mellon's Enfusion, Inc. position peaked at $9.7M in Q1 2022.
• 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.